We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$12.8B
AUM Growth
-$896M
Cap. Flow
-$396M
Cap. Flow %
-3.08%
Top 10 Hldgs %
24.99%
Holding
3,035
New
97
Increased
329
Reduced
999
Closed
146

Sector Composition

Rank Sector Weight
1 Technology 25.12%
2 Healthcare 12.03%
3 Financials 11.49%
4 Consumer Discretionary 10.97%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPLI
2676
People Inc
PPLI
$3B
$74K ﹤0.01%
1,791
-64
-3% -$3.1K
CMAX
2677
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$73.9K ﹤0.01%
1,161
ACTG icon
2678
Acacia Research
ACTG
$453M
$73.7K ﹤0.01%
20,191
ATRA icon
2679
Atara Biotherapeutics
ATRA
$77M
$73.6K ﹤0.01%
1,989
CRD.A icon
2680
Crawford & Co Class A
CRD.A
$621M
$73.5K ﹤0.01%
7,866
ERAS icon
2681
Erasca
ERAS
$6.39B
$73.4K ﹤0.01%
37,277
JILL icon
2682
J. Jill
JILL
$283M
$73.3K ﹤0.01%
+2,478
New +$58.1K
SMLR
2683
DELISTED
Semler Scientific
SMLR
$73.2K ﹤0.01%
2,885
RGCO icon
2684
RGC Resources
RGCO
$222M
$73K ﹤0.01%
4,218
BWFG icon
2685
Bankwell Financial Group
BWFG
$542M
$72.9K ﹤0.01%
3,003
FENC icon
2686
Fennec Pharmaceuticals
FENC
$429M
$72.7K ﹤0.01%
9,679
NOTE
2687
DELISTED
FiscalNote
NOTE
$72.4K ﹤0.01%
2,901
BRCC icon
2688
BRC Inc
BRCC
$212M
$72.4K ﹤0.01%
20,157
JYNT icon
2689
The Joint Corp
JYNT
$120M
$72.3K ﹤0.01%
8,041
BCOV
2690
DELISTED
Brightcove, Inc.
BCOV
$72.1K ﹤0.01%
21,912
JAKK icon
2691
Jakks Pacific
JAKK
$291M
$72K ﹤0.01%
3,871
LSEA
2692
DELISTED
Landsea Homes
LSEA
$71.3K ﹤0.01%
+7,933
New +$79.5K
XFOR icon
2693
X4 Pharmaceuticals
XFOR
$430M
$71.3K ﹤0.01%
2,181
OPRX icon
2694
OptimizeRx
OPRX
$148M
$71.2K ﹤0.01%
9,158
ESSA
2695
DELISTED
ESSA Bancorp
ESSA
$71.1K ﹤0.01%
4,734
TIO
2696
DELISTED
Tingo Group, Inc. Common Stock
TIO
$71K ﹤0.01%
69,262
NREF
2697
NexPoint Real Estate Finance
NREF
$322M
$71K ﹤0.01%
+4,339
New +$71.9K
JBIO
2698
Jade Biosciences
JBIO
$1.47B
$70.9K ﹤0.01%
149
CDZI icon
2699
Cadiz
CDZI
$301M
$70.7K ﹤0.01%
21,362
ATOM icon
2700
Atomera
ATOM
$215M
$70.6K ﹤0.01%
11,274

Similar funds

MetLife Investment Management's Q3 2023 Portfolio in Review

As of Q3 2023, MetLife Investment Management held 3,035 positions worth $12.8B, down 6.5% from $13.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management withdrew a net $396M in Q3 2023, closing 146 positions and reducing 999 holdings. Its most notable exit was Accenture, an estimated $57.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Kenvue worth $9.06M.

  • MetLife Investment Management's largest Q3 2023 buy was Kenvue: 451,001 shares worth $9.06M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $37.9M increase.
  • MetLife Investment Management's biggest Q3 2023 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $125M.
  • MetLife Investment Management fully exited Accenture in Q3 2023, selling an estimated $57.6M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.8B portfolio in Q3 2023.
  • MetLife Investment Management opened 97 new positions and closed 146 in Q3 2023.
  • MetLife Investment Management's portfolio value fell 6.5% quarter-over-quarter to $12.8B.

Based on MetLife Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.